Dar Al-Shifa Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Dar Al-Shifa Pharmaceuticals Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Dar Al-Shifa Pharmaceuticals were recently set by distinguished experts, with an average mark of 3.71. If it reached this goal, it would represent a potential upside of approximately 12.42% from the previous closing price in October, 2021. The high end is 4.16, and the low is 3.30. If you want to invest in PHARMACARE stock, you might also want to take a look at how its competitors are doing.
12.42% Upside
Dar Al-Shifa Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Price for Dar Al-Shifa Pharmaceuticals has grown by 100.00%, going from 0.00 to 0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach 3.22 – an increase of 100.00%. Over the next eight years, experts anticipate that Fair Value growth for Dar Al-Shifa Pharmaceuticals will be 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$734.37 | Buy/Sell | $636.99 | 10.71% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$161.23 | Buy/Sell | $174.55 | 5.44% |
MRK Stock Forecast | Merck | Outperform |
2
|
$122.77 | Buy/Sell | $130.51 | 9.96% |
AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£104.50 | Buy/Sell | £165.99 | 53.79% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$54.36 | Buy/Sell | $58.15 | 1.18% |
VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$414.47 | Buy/Sell | $457.59 | 8.57% |
REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$964.44 | Buy/Sell | $961.26 | 8.87% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GSK Stock Forecast | GSK | Outperform |
12
|
£16.75 | Buy/Sell | £17.30 | 11.04% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$183.49 | Buy/Sell | $220.47 | 20.72% |
MRK Stock Forecast | Merck KGaA | Outperform |
18
|
156.75€ | Buy/Sell | 190.06€ | 9.73% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
AGN Stock Forecast | Allergan | - |
0
|
$47.83 | Buy/Sell | $193.25 | -100.00% |
BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$43.48 | Buy/Sell | $44.86 | 3.50% |
ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.10 | Buy/Sell | $245.24 | 44.20% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.97 | Buy/Sell | $11.73 | 0.25% |
UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$249.51 | Buy/Sell | $284.08 | 19.63% |
CTLT Stock Forecast | Catalent | Hold |
15
|
$56.81 | Buy/Sell | $49.29 | 11.78% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IPN Stock Forecast | Ipsen | Outperform |
17
|
106.40€ | Buy/Sell | 127.95€ | 9.96% |
CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$64.39 | Buy/Sell | $87.92 | 45.99% |
IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$43.26 | Buy/Sell | $55.60 | 41.01% |
Dar Al-Shifa Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, EPS for Dar Al-Shifa Pharmaceuticals has grown by 100.00%, going from 0.00 to 0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach 0.00 – an increase of 100.00%. Over the next eight years, experts anticipate that EPS growth for Dar Al-Shifa Pharmaceuticals will be 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.10 | Buy/Sell | £28.11 | 55.34% |
DPH Stock Forecast | Dechra Pharmaceuticals PLC | - |
18
|
£38.66 | Buy/Sell | £39.86 | -45.73% |
BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.04 | Buy/Sell | $145.00 | 4.46% |